Jazz Pharmaceuticals plc (JAZZ)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 480 |
| % of all portfolios: | 0.013% |
| Hold Price * : | $240.97 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q2 2026 | |||||
| ≡ | Polen Capital Management | Buy | 1,858 | 0.00 | |
| ≡ | Tweedy Browne | Reduce 0.10% | 60 | 0.00 | |
| Q1 2026 | |||||
| ≡ | Tweedy Browne | Buy | 60,209 | 0.90 | |
| Q3 2024 | |||||
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 1,274,248 | 3.85 | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 4,187 | 0.01 | |
| ≡ | Seth Klarman - Baupost Group | Add 52.84% | 440,552 | 1.33 | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 4,187 | 0.01 | |
| Q4 2023 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 23.75% | 160,000 | 0.43 | |
| Q2 2023 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 40.74% | 195,000 | 0.44 | |
| Q1 2023 | |||||
| ≡ | Seth Klarman - Baupost Group | Buy | 478,696 | 1.25 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 10,120 | 0.01 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 60.86% | 15,738 | 0.02 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 39.55% | 7,329 | 0.01 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 104.76% | 9,480 | 0.02 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 9,049 | 0.02 | |
| Q2 2019 | |||||
| ≡ | Viking Global Investors | Sell 100.00% | 635,736 | 0.52 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.